Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas. [electronic resource]
Producer: 19980429Description: 214-20 p. digitalISSN:- 0910-5050
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Female
- Gene Expression Regulation, Neoplastic
- Genes, p53
- Humans
- Kidney Neoplasms -- drug therapy
- Kidney Pelvis
- Male
- Middle Aged
- Nuclear Proteins
- Prognosis
- Proto-Oncogene Proteins -- biosynthesis
- Proto-Oncogene Proteins c-mdm2
- Treatment Outcome
- Tumor Suppressor Protein p53 -- biosynthesis
- Ureteral Neoplasms -- drug therapy
- Urinary Bladder Neoplasms -- drug therapy
- Urologic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.